2020
DOI: 10.1007/s00726-020-02890-9
|View full text |Cite
|
Sign up to set email alerts
|

Impact of non-proteinogenic amino acids in the discovery and development of peptide therapeutics

Abstract: With the development of modern chemistry and biology, non-proteinogenic amino acids (NPAAs) have become a powerful tool for developing peptide-based drug candidates. Drug-like properties of peptidic medicines, due to the smaller size and simpler structure compared to large proteins, can be changed fundamentally by introducing NPAAs in its sequence. While peptides composed of natural amino acids can be used as drug candidates, the majority have shown to be less stable in biological conditions. The impact of NPA… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
76
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 102 publications
(96 citation statements)
references
References 185 publications
0
76
0
1
Order By: Relevance
“…Nonetheless, they are also more prone to degradation as compared to small moleculebased drugs. To overcome this limitation, non-natural amino acids and/or cyclization can be introduced to enhance peptide stability (Ding et al, 2020). Numerous AMP-based drugs are currently evaluated in clinical trials [as reviewed in Mookherjee et al (2020)] for a variety of potential applications, such as antimicrobial therapies and immunomodulatory therapies.…”
Section: Resultsmentioning
confidence: 99%
“…Nonetheless, they are also more prone to degradation as compared to small moleculebased drugs. To overcome this limitation, non-natural amino acids and/or cyclization can be introduced to enhance peptide stability (Ding et al, 2020). Numerous AMP-based drugs are currently evaluated in clinical trials [as reviewed in Mookherjee et al (2020)] for a variety of potential applications, such as antimicrobial therapies and immunomodulatory therapies.…”
Section: Resultsmentioning
confidence: 99%
“…Due to the great diversity in their physicochemical characteristics, these NPAAs can be used to improve peptide stability, permeability. and potency, thereby contributing to better bioavailability 136 . First of all, stability can be improved by stabilizing the backbone configuration or eliminating the enzyme recognition sites, avoiding proteolysis.…”
Section: Discovery and Development Of Peptide‐based Kv13 Inhibitorsmentioning
confidence: 99%
“…Firstly, peptides, especially short ones, can readily be prepared by well-established solid-phase methods, also for ease of purification [ 2 ]. Secondly, they allow greater chemical diversity, relative to other classes of compounds, which has been further expanded by the introduction of a large variety of non-natural amino acids [ 3 , 4 ]. Thirdly, as the complex function of proteins can be pinned to specific sets of peptide sequences, it has been shown that peptides can encode for at least some of protein functionalities [ 5 ].…”
Section: Introductionmentioning
confidence: 99%